969 related articles for article (PubMed ID: 25472645)
1. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival after pancreatic resection for renal cell carcinoma metastasis.
Schwarz L; Sauvanet A; Regenet N; Mabrut JY; Gigot JF; Housseau E; Millat B; Ouaissi M; Gayet B; Fuks D; Tuech JJ
Ann Surg Oncol; 2014 Nov; 21(12):4007-13. PubMed ID: 24879589
[TBL] [Abstract][Full Text] [Related]
3. Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.
Johannsen M; Flörcken A; Bex A; Roigas J; Cosentino M; Ficarra V; Kloeters C; Rief M; Rogalla P; Miller K; Grünwald V
Eur Urol; 2009 Jun; 55(6):1430-8. PubMed ID: 18950936
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
[TBL] [Abstract][Full Text] [Related]
5. Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre.
De Lichtenberg TH; Hermann GG; Rørth M; Højer Larsen MJ; Mansourvar Z; Holm ML; Scheike T
Scand J Urol; 2014 Aug; 48(4):379-86. PubMed ID: 24521185
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center.
Grassi P; Verzoni E; Mariani L; De Braud F; Coppa J; Mazzaferro V; Procopio G
Clin Genitourin Cancer; 2013 Dec; 11(4):484-8. PubMed ID: 23791435
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
[TBL] [Abstract][Full Text] [Related]
8. Survival data justifies resection for pancreatic metastases.
Strobel O; Hackert T; Hartwig W; Bergmann F; Hinz U; Wente MN; Fritz S; Schneider L; Büchler MW; Werner J
Ann Surg Oncol; 2009 Dec; 16(12):3340-9. PubMed ID: 19777190
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
10. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.
Hallemeier CL; Choo R; Davis BJ; Pisansky TM; Gunderson LL; Leibovich BC; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1938-43. PubMed ID: 21514065
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma metastatic to the pancreas: clinical and radiological features.
Ghavamian R; Klein KA; Stephens DH; Welch TJ; LeRoy AJ; Richardson RL; Burch PA; Zincke H
Mayo Clin Proc; 2000 Jun; 75(6):581-5. PubMed ID: 10852418
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
Kalra S; Atkinson BJ; Matrana MR; Matin SF; Wood CG; Karam JA; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
BJU Int; 2016 May; 117(5):761-5. PubMed ID: 26032863
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors.
Chrom P; Stec R; Bodnar L; Szczylik C
Anticancer Res; 2018 Jan; 38(1):359-365. PubMed ID: 29277795
[TBL] [Abstract][Full Text] [Related]
16. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
[TBL] [Abstract][Full Text] [Related]
17. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC
Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246
[TBL] [Abstract][Full Text] [Related]
18. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience.
Renaud S; Falcoz PE; Alifano M; Olland A; Magdeleinat P; Pagès O; Regnard JF; Massard G
J Surg Oncol; 2014 Jun; 109(8):823-9. PubMed ID: 24619772
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic resection for metastatic renal cell carcinoma: a single center experience and review of the literature.
Schauer M; Vogelsang H; Siewert JR
Anticancer Res; 2008; 28(1B):361-5. PubMed ID: 18383870
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma.
Iesalnieks I; Machens A; Bures C; Krenz D; Winter H; Vorländer C; Bareck E; Alesina PF; Musholt T; Steinmüller T; Anthuber M; Goretzki P; Trupka A; Mayr M; Weber T; Schlitt HJ; Dralle H; Hermann M; Agha A
Ann Surg Oncol; 2015; 22(6):1798-805. PubMed ID: 25472649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
